HS 3002 · Pharmaceutical products
Vaccines, blood and immunological products
Data last updated 18 October 2026 · schedule data 2026.10.2
In short
The EU charges no duty on Mercosur vaccines and immunological products, with or without the agreement; Brazil's duty on EU vaccines and immunological products is up to 8.8% today and reaches zero by 2036 (on most lines by 2034, 1 of 57 lines is excluded).
Rates at a glance
Into the EU from Mercosur
9 tariff linesPreferential duty 2026
0%
Duty-free on all phased lines by
No phase-out
Agreement base rate
0%
Applied MFN rate today
0%
Into Brazil from the EU
57 tariff linesPreferential duty 2026
0–8.8%
Duty-free on all phased lines by
2036
Agreement base rate
0–10%
Applied MFN rate today
–
Work out the duty on your shipment
Opens the calculator with heading 3002 and the corridor filled in.
About this product
Vaccines, antisera and blood products already enter the EU duty-free. Mercosur phases out its duties on European vaccines and immunological products, mostly within a few years, with one line excluded. Public tenders and health registration still decide much of this trade.
How the duty falls, year by year
Highest and lowest ad valorem duty each year over the lines on a path to zero. Excluded and quota-only lines keep their duty and aren't included.
Into the EU from Mercosur
Nothing to phase out in this direction: every line is already duty-free, excluded or only covered by a quota.
Into Brazil from the EU
| Year | Ad valorem duty | Lines duty-free |
|---|---|---|
| 2026 | 0–8.8% | 4 / 57 |
| 2027 | 0–7.7% | 4 / 57 |
| 2028 | 0–6.6% | 4 / 57 |
| 2029 | 0–5.5% | 4 / 57 |
| 2030 | 0–4.4% | 42 / 57 |
| 2031 | 0–3.6% | 42 / 57 |
| 2032 | 0–2.9% | 42 / 57 |
| 2033 | 0–2.1% | 42 / 57 |
| 2034 | 0–1.4% | 55 / 57 |
| 2035 | 0–0.7% | 55 / 57 |
| 2036 | 0% | 56 / 57 |
Lines by staging category
The staging category sets the speed of the cut: 0 is duty-free from entry into force, 4 to 15 are the years to zero, E is excluded and letter codes are quotas or special treatments.
Mercosur → EU
- 0× 9
EU → Mercosur
- 4× 38
- 8× 13
- 0× 4
- 10× 1
- E× 1
Tariff-rate quotas
No tariff-rate quota applies to this heading.
Rates in each Mercosur country
Each member has its own base rate and applied MFN rate. The preference is cut from the base rate, or from the applied rate where that's lower (Art. 2.4(7) of the agreement), so the current rate can differ by country.
| Country | Base rate | Applied MFN | Preferential 2026 | Zero by | Applied-rate source |
|---|---|---|---|---|---|
| Brazil | 0–10% | –57 lines have no single published rate | 0–8.8% | 2036 | Brazil applied import duty, Res. Gecex 272/2021 Annexes II, V, VI, IX (MDIC), as of 5 October 2026 |
| Argentina | 0–10% | –57 lines have no single published rate | 0–8.8% | 2036 | Argentina applied import duty (DIE), ARCA Arancel Integrado, as of 18 October 2026 |
| Uruguay | 0–10% | –57 lines have no single published rate | 0–8.8% | 2036 | Uruguay applied import duty (Arancel Nacional, MEF), as of 10 February 2025Manual snapshot |
| Paraguay | 0–10% | –57 lines have no single published rate | 0–8.8% | 2036 | Paraguay applied import duty (Arancel Nacional Vigente, MEF), as of 4 November 2025Manual snapshot |
All tariff lines
Line descriptions are the English text of the schedules (CN 2013 for the EU, NCM 2012 for Mercosur).
Into the EU from Mercosur: 9 lines
| Code | Description | Staging | Base | Applied MFN | 2026 | Final |
|---|---|---|---|---|---|---|
| 3002 10 10 | Antisera | 0 | Free | Free | Free | Free |
| 3002 10 91 | Haemoglobin, blood globulins and serum globulins | 0 | Free | Free | Free | Free |
| 3002 10 98 | Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins) | 0 | Free | Free | Free | Free |
| 3002 20 00 | Vaccines for human medicine | 0 | Free | Free | Free | Free |
| 3002 30 00 | Vaccines for veterinary medicine | 0 | Free | Free | Free | Free |
| 3002 90 10 | Human blood | 0 | Free | Free | Free | Free |
| 3002 90 30 | Animal blood prepared for therapeutic, prophylactic or diagnostic uses | 0 | Free | Free | Free | Free |
| 3002 90 50 | Cultures of micro-organisms (excl. yeasts) | 0 | Free | Free | Free | Free |
| 3002 90 90 | Toxins and similar products, e.g. plasmodia (excl. vaccines and cultures of micro- organisms) | 0 | Free | Free | Free | Free |
Into Brazil from the EU: 57 lines
| Code | Description | Staging | Base | Applied MFN | 2026 | Final |
|---|---|---|---|---|---|---|
| 3002 10 11 | Antiophidic serums and other serums anti- poisonous | 8 | 8% | – | 7.1% | Freefrom 2034 |
| 3002 10 12 | Antitetanic serum | 4 | 4% | – | 3.2% | Freefrom 2030 |
| 3002 10 13 | Anticatarrh serum | 8 | 4% | – | 3.5% | Freefrom 2034 |
| 3002 10 14 | Antipyogens serum | 8 | 4% | – | 3.5% | Freefrom 2034 |
| 3002 10 15 | Antidiphtheria serum | 8 | 4% | – | 3.5% | Freefrom 2034 |
| 3002 10 16 | Antiserum polyvalent | 8 | 4% | – | 3.5% | Freefrom 2034 |
| 3002 10 19 | Other antiserum specific of animals/humans, immunized | 4 | 2% | – | 1.6% | Freefrom 2030 |
| 3002 10 22 | Anti-Rh immunoglobulin | 4 | 2% | – | 1.6% | Freefrom 2030 |
| 3002 10 23 | Other serum immunoglobulins | 4 | 2% | – | 1.6% | Freefrom 2030 |
| 3002 10 24 | Factor VIII concentrate | 4 | 2% | – | 1.6% | Freefrom 2030 |
| 3002 10 25 | Serum albumin in gel format, for reagent preparations for diagnostics | 4 | 2% | – | 1.6% | Freefrom 2030 |
| 3002 10 26 | Monoclonal antibodies in buffer solution containing bovine albumin | 4 | 2% | – | 1.6% | Freefrom 2030 |
| 3002 10 29 | Other blood fractions and immunological products prepared as medicine | 4 | 2% | – | 1.6% | Freefrom 2030 |
| 3002 10 31 | Serum albumin, except human | 4 | 2% | – | 1.6% | Freefrom 2030 |
| 3002 10 32 | Plasmin (fibrinolysin) | 0 | Free | – | Free | Free |
| 3002 10 33 | Urokinase | 0 | Free | – | Free | Free |
| 3002 10 34 | Immunoglobin and histamine hydrochloride, in association | 8 | 8% | – | 7.1% | Freefrom 2034 |
| 3002 10 35 | Immunoglobin G, lyophilized or in solution | 8 | 8% | – | 7.1% | Freefrom 2034 |
| 3002 10 36 | Interferon beta | 0 | Free | – | Free | Free |
| 3002 10 37 | Human serum albumin | 4 | 4% | – | 3.2% | Freefrom 2030 |
| 3002 10 38 | Human antibody with specificity trans- membrane antigen | 0 | Free | – | Free | Free |
| 3002 10 39 | Other blood fractions, modified immunological products | E | 2% | – | 2% | 2% |
| 3002 20 11 | Vaccines against flu, except in doses | 4 | 2% | – | 1.6% | Freefrom 2030 |
| 3002 20 12 | Vaccines against poliomyelitis, except in doses | 4 | 2% | – | 1.6% | Freefrom 2030 |
| 3002 20 13 | Vaccines against hepatitis B, except in doses | 4 | 2% | – | 1.6% | Freefrom 2030 |
| 3002 20 14 | Vaccines against measles, except in doses | 4 | 2% | – | 1.6% | Freefrom 2030 |
| 3002 20 15 | Vaccines against meningitis, except in doses | 4 | 2% | – | 1.6% | Freefrom 2030 |
| 3002 20 16 | Vaccines against rubella, measles, mumps, except in doses | 4 | 2% | – | 1.6% | Freefrom 2030 |
| 3002 20 17 | Other triple vaccines, except in doses | 8 | 4% | – | 3.5% | Freefrom 2034 |
| 3002 20 18 | Vaccines anticatarrh and antipyogen, except in doses | 4 | 2% | – | 1.6% | Freefrom 2030 |
| 3002 20 19 | Other vaccines for human medicine, except in doses | 4 | 2% | – | 1.6% | Freefrom 2030 |
| 3002 20 21 | Vaccines against flu, in doses | 4 | 2% | – | 1.6% | Freefrom 2030 |
| 3002 20 22 | Vaccines against poliomyelitis, in doses | 4 | 2% | – | 1.6% | Freefrom 2030 |
| 3002 20 23 | Vaccines against hepatitis B, in doses | 4 | 2% | – | 1.6% | Freefrom 2030 |
| 3002 20 24 | Vaccines against measles, in doses | 4 | 2% | – | 1.6% | Freefrom 2030 |
| 3002 20 25 | Vaccines against meningitis, in doses | 4 | 2% | – | 1.6% | Freefrom 2030 |
| 3002 20 26 | Vaccines against rubella, measles, mumps, in doses | 4 | 2% | – | 1.6% | Freefrom 2030 |
| 3002 20 27 | Other triple vaccines, in doses | 4 | 2% | – | 1.6% | Freefrom 2030 |
| 3002 20 28 | Vaccines anti-catarrh and antipyogen, in doses | 4 | 4% | – | 3.2% | Freefrom 2030 |
| 3002 20 29 | Other vaccines for human medicine, in doses | 4 | 2% | – | 1.6% | Freefrom 2030 |
| 3002 30 10 | Veterinary vaccines, against rabies | 4 | 4% | – | 3.2% | Freefrom 2030 |
| 3002 30 20 | Veterinary vaccines, against coccidiosis | 4 | 4% | – | 3.2% | Freefrom 2030 |
| 3002 30 30 | Veterinary vaccines, against keratoconjunctivitis | 4 | 4% | – | 3.2% | Freefrom 2030 |
| 3002 30 40 | Veterinary vaccines, against distemper | 4 | 4% | – | 3.2% | Freefrom 2030 |
| 3002 30 50 | Veterinary vaccines, against leptospirosis | 8 | 4% | – | 3.5% | Freefrom 2034 |
| 3002 30 60 | Veterinary vaccines, against foot-and- mouth | 4 | 4% | – | 3.2% | Freefrom 2030 |
| 3002 30 70 | Veterinary vaccines, diseases: Newcastle, Gumboro, etc. | 4 | 4% | – | 3.2% | Freefrom 2030 |
| 3002 30 80 | Combined veterinary vaccines against diseases as Newcastle, Gumboro, etc. | 4 | 4% | – | 3.2% | Freefrom 2030 |
| 3002 30 90 | Other vaccines for veterinary medicine | 4 | 2% | – | 1.6% | Freefrom 2030 |
| 3002 90 10 | Diagnostic reagents of microbial origin | 8 | 10% | – | 8.8% | Freefrom 2034 |
| 3002 90 20 | Anti-toxins of microbial origin | 8 | 4% | – | 3.5% | Freefrom 2034 |
| 3002 90 30 | Tuberculins | 4 | 4% | – | 3.2% | Freefrom 2030 |
| 3002 90 91 | Other toxic, cultures of microorganisms, for animal health | 4 | 4% | – | 3.2% | Freefrom 2030 |
| 3002 90 92 | Other toxic, cultures of microorganisms, for human health | 4 | 4% | – | 3.2% | Freefrom 2030 |
| 3002 90 93 | Saxitoxin | 8 | 8% | – | 7.1% | Freefrom 2034 |
| 3002 90 94 | Ricin | 8 | 8% | – | 7.1% | Freefrom 2034 |
| 3002 90 99 | Other toxic, cultures of microorganisms, similar products | 10 | 8% | – | 7.2% | Freefrom 2036 |
Related products
Data and method
Worked out with the calculator's engine from the agreement schedules (Annex 2-A) and the applied-rate files, for agreement year 2026. Mercosur → EU figures assume Brazilian origin, which only matters for the few origin-specific quotas; EU → Mercosur figures are for Brazil unless the country table says otherwise.
- EU TARIC via Swedish Customs Tariff File Distribution (TF), 16 October 2026
- Brazil applied import duty, Res. Gecex 272/2021 Annexes II, V, VI, IX (MDIC), 5 October 2026
- Argentina applied import duty (DIE), ARCA Arancel Integrado, 18 October 2026
- Uruguay applied import duty (Arancel Nacional, MEF), 10 February 2025 · Manual snapshot
- Paraguay applied import duty (Arancel Nacional Vigente, MEF), 4 November 2025 · Manual snapshot
Estimates only, not legal or customs advice. Check the official schedules before relying on a rate.